Cargando…

SARS-CoV-2 messenger RNA vaccination during herpes zoster infection in an elderly man

Detalles Bibliográficos
Autores principales:	Katayama, Sho, Ota, Mitsuhito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Notes & Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926427/ https://www.ncbi.nlm.nih.gov/pubmed/35313557 http://dx.doi.org/10.1016/j.jdcr.2022.03.019

Ejemplares similares

SARS-CoV-2 mRNA vaccination and subsequent herpes zoster: Possible immune reconstitution by mRNA vaccination
por: Ota, Mitsuhito
Publicado: (2022)

Herpes zoster dermatitis in a COVID-19 vaccinated healthy man after 1 dose of varicella vaccine
por: Etaee, Farshid, et al.
Publicado: (2022)

Cutaneous skin manifestation following messenger RNA Moderna SARS-CoV-2 vaccine with dermal hypersensitivity reaction histopathology
por: Chopra, Shara, et al.
Publicado: (2021)

Hemorrhagic herpes zoster duplex unilateralis in a patient taking clopidogrel
por: Miller, Austinn C., et al.
Publicado: (2023)

Response to “Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases”
por: Lim, Ziying Vanessa, et al.
Publicado: (2022)

Disseminated herpes zoster following inactivated SARS-CoV-2 vaccine in a healthy old man
por: Zhang, Li-wen, et al.
Publicado: (2022)

Multiple granuloma annulare lesions presenting simultaneously with herpes zoster infection: Wolf's isotopic response
por: Al Ali, Aisha, et al.
Publicado: (2018)

Concurrent presentation of tumid lupus with herpes zoster infection: A variant of Wolf isotopic response?
por: Tappel, Anna, et al.
Publicado: (2019)

Single-dose SARS-CoV-2 vaccination efficacy in the elderly
por: Prendecki, Maria, et al.
Publicado: (2021)

Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine
por: Drohan, Alex, et al.
Publicado: (2021)

Letter in Reply: Alopecia areata after SARS-CoV-2 vaccination
por: Lo, Angela, et al.
Publicado: (2022)

Zosteriform Lesions in an Elderly Man-Look Beyond Herpes Zoster
por: Raveendra, Leena, et al.
Publicado: (2015)

Credibility and evidence in the handling of SARS-CoV-2
por: Velilla-Jiménez, Helbert E.
Publicado: (2021)

Is Herpes Zoster Contagious?
Publicado: (1885)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Optimising SARS-CoV-2 vaccination schedules
por: Belda-Iniesta, Cristobal
Publicado: (2021)

Herpes simplex, herpes zoster and periorbital erythema flares after SARS-CoV-2 vaccination: 4 cases
por: Kluger, N., et al.
Publicado: (2022)

Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021)

SARS-CoV-2 evolution and vaccines: cause for concern?
por: Williams, Thomas C, et al.
Publicado: (2021)

Stroke after SARS-CoV-2 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Under the spell of SARS-CoV-2: A closer look at the sociopolitical dynamics
por: Khetrapal, Neha, et al.
Publicado: (2021)

Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination
por: Channa, Leelakrishna, et al.
Publicado: (2021)

Erythema Multiforme after BNT162b2 Vaccination
por: Katayama, Sho, et al.
Publicado: (2022)

The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
por: Shang, Weilong, et al.
Publicado: (2020)

SARS-CoV-2 vaccines: fast track versus efficacy
por: Alkandari, Dana, et al.
Publicado: (2021)

Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

Balancing risk and benefit of SARS-CoV-2 vaccines in children
por: Levin, Michael, et al.
Publicado: (2022)

Affordable SARS-CoV-2 protein vaccines for the pandemic endgame
por: Triccas, James A., et al.
Publicado: (2022)

Guillain-Barre syndrome related to SARS-CoV-2 vaccinations
por: Finsterer, Josef, et al.
Publicado: (2022)

SARS-CoV-2 vaccine strategies in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2023)

Stroke seven hours after SARS-CoV-2 vaccination
por: Fiorini, Ana Claudia, et al.
Publicado: (2023)

How can science be well-ordered in times of crisis? Learning from the SARS-CoV-2 pandemic
por: Reydon, Thomas A. C.
Publicado: (2020)

Histopathologic correlation of skin manifestations of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection
por: So, Naomi A., et al.
Publicado: (2021)

Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study
por: Birabaharan, Morgan, et al.
Publicado: (2022)

A promising inactivated whole-virion SARS-CoV-2 vaccine
por: Isakova-Sivak, Irina, et al.
Publicado: (2021)

SARS-CoV-2 vaccination and phase 1 cancer clinical trials
por: Yap, Timothy A, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in IBD: more pros than cons
por: D’Amico, Ferdinando, et al.
Publicado: (2021)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine
por: Kennedy, Richard B
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rcpk3lhsfnpdlr9hr5p4b9tv07